Evidence map›Paper›PMID 40693798›Full record

ArticleJournal of biomedical materials research. Part B, Applied biomaterials2025

Aligned Collagen Sponges Loaded With Myogenic Factors to Enhance Skeletal Muscle Tissue Regeneration.

Natalie G Kozan, Sean Caswell, Shreyas Bolla, Jonathan M Grasman

Abstract read
In one paragraph

Article in Journal of biomedical materials research. Part B, Applied biomaterials, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Natalie G KozanDepartment of Biomedical Engineering, New Jersey Institute of Technology, Newark, New Jersey, USA.
Sean CaswellDepartment of Biomedical Engineering, New Jersey Institute of Technology, Newark, New Jersey, USA.
Shreyas BollaDepartment of Biomedical Engineering, New Jersey Institute of Technology, Newark, New Jersey, USA.
Jonathan M GrasmanDepartment of Biomedical Engineering, New Jersey Institute of Technology, Newark, New Jersey, USA.ORCID 0000-0001-8289-9627

Funding

Institutional Career Development CoreKL2TR003018 · NCATS · RUTGERS BIOMEDICAL/HEALTH SCIENCES-RBHS · PI CHAN, JOHN R., HALM, ETHAN A · 2019 to 2023
$3.0M
Acellular composite hydrogel scaffolds for volumetric muscle regenerationR21AR079708 · NIAMS · NEW JERSEY INSTITUTE OF TECHNOLOGY · PI GRASMAN, JONATHAN M., KUMAR, VIVEK · 2022 to 2023
$467k
NCATS NIH HHS KL2 TR003018NIAMS NIH HHS R21 AR079708NIH HHS KL2-TR003018NIH HHS R21-AR079708
6 · The paper itself

Abstract

Volumetric muscle loss (VML) is an injury which leads to debilitating loss of functionality of a muscle. Autologous tissue grafts are used as a standard treatment; however, these grafts often result in complications. Current scaffolds are limited in their ability to restore functionality of the injured muscle, which may be due to lack of cell recruitment to the scaffold and/or lack of sufficient myofiber formation. Our approach involves the controlled release of insulin-like growth factor-1 (IGF-1) from a biopolymer scaffold, as IGF-1 enhances both the proliferation and differentiation of myoblasts, which we hypothesize will enhance regeneration after VML. In this study, to facilitate a more controlled release of IGF-1, we added IGF-binding protein 5 (IGFBP-5) to anisotropic collagen sponges with finely tuned pore sizes via heparin conjugation to stabilize the IGFBP-5/IGF-1 complex. Scaffolds containing heparin, IGFBP-5, and IGF-1 induced the highest level of myofiber formation for up to 4 weeks, suggesting this scaffold system supported the sustained release of active IGF-1. Future studies will be used to implant these scaffolds into mouse models of VML and determine their effects on regeneration in vivo as well as on restoration of force production of the muscle.

Indexed as

CollagenInsulin-Like Growth Factor Binding Protein 5Insulin-Like Growth Factor IMuscle, SkeletalRegenerationTissue ScaffoldsAnimalsDelayed-Action PreparationsHeparinMiceCollagenDelayed-Action PreparationsHeparinInsulin-Like Growth Factor Binding Protein 5Insulin-Like Growth Factor Iinsulin‐like growth factor‐1insulin‐like growth factor binding protein‐5skeletal muscletissue engineeringvolumetric muscle loss

Identifiers

PMID40693798
PMCPMC13014528

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.